US President Donald Trump is expected to announce new agreements on Friday (December 19) aimed at lowering prescription drug prices, the White House said. The announcement is scheduled for 1 p.m. ET at the White House.AbbVie, Bristol Myers Squibb, Gilead Sciences, and Merck are among the major pharmaceutical companies expected to participate, Reuters reporting citing sources familiar with the matter.Swiss drugmakers Novartis and Roche are also reportedly part of the deals, according to Bloomberg News.Backgr ...

We recently published 12 Stocks on Jim Cramer’s Radar.  Merck & Co., Inc. (NYSE:MRK) is one of the stocks on Jim Cramer's radar. Merck & Co., Inc. (NYSE:MRK) is one of the largest pharmaceutical companies in the world. Its shares are flat year-to-date and would have been lower had it not been for a run that started on November 3rd. During this time period, Merck & Co., Inc. (NYSE:MRK) has benefited from several catalysts, which include optimistic data about its heart drug called Winrevair. On November 18t ...

经济观察网12月19日默沙东宣布，近日在《北京市促进临床急需药械临时进口工作实施方案(试行)》、 《北京市推动罕见病药品保障先行区建设工作实施方案(试行)》等政策的支持下，中国医学科学院阜外 医院获批临时进口sotatercept(WINREVAIR)。 Sotatercept是全球首个且目前唯一用于治疗PAH的激活素信号传导抑制剂(ASI)，可以捕获过量激活素 A，帮助恢复失衡的信号通路，抑制细胞增殖进而改善血管结构和恢复管腔通畅，曾获得过美国突破性 疗法认定、孤儿药资格认定，以及欧盟优先药品资格认定、孤儿药资格认定，并先后于2024年3月、 2024年8月获得美国食品药品监督管理局(FDA)、欧洲药品管理局(EMA)批准。 PAH是一种多种因素引起的罕见、进展性且危及生命的血管疾病，其特征是由于肺动脉重构导致肺动脉 狭窄，最终引起肺动脉压力增加，肺血管阻力升高，最终引起肺小动脉的收缩和肺循环中的血压升高。 若得不到及时有效的治疗，最终会发展为右心衰竭甚至危及生命。其中，特发性肺动脉高压已于2018年 被纳入国家卫生健康委公布的《第一批罕见病目录》。 ...

Core Insights - US core inflation unexpectedly eased to a four-year low, raising questions among economists about the reliability of the data due to a prior government shutdown [8][14] - ByteDance has signed an agreement to establish a joint venture in the US with majority ownership by American investors [8][14] Market Performance - The A-share market opened lower but closed higher, with the Shanghai Composite Index up 0.16% at 3876.37 points, while the Shenzhen Component fell 1.29% and the ChiNext Index dropped 2.17% [1] - The Hong Kong market also saw fluctuations, with the Hang Seng Index closing up 0.12% at 25498.13 points, while the Hang Seng Tech Index fell 0.73% [1][5] Economic Indicators - The US core Consumer Price Index (CPI) rose by 2.6% year-on-year in November, while the overall CPI increased by 2.7% [14] - The report indicated that core CPI only increased by 0.2% over the last two months, with declines in hotel, leisure, and clothing prices limiting the overall increase [14] Corporate Developments - TikTok announced the establishment of a joint venture with US investors, which will operate independently and manage US data protection and algorithm security [8][14] - China has reportedly ordered 7 million tons of US soybeans, achieving over half of the procurement target set during the Trump administration [8][14]

Core Insights - Merck (MRK) has significantly contributed to the resurgence of the S&P 500 Health Care sector in recent months, achieving a return of 29% since mid-June, outperforming the sector overall [1] Group 1: Company Performance - Merck's stock performance has been notably strong, with a 29% increase since mid-June, indicating robust investor confidence and market positioning [1] Group 2: Market Context - The resurgence of the S&P 500 Health Care sector has been influenced by key players like Merck, highlighting the company's role in driving sector performance [1]

Core Insights - Merck (MRK) has significantly contributed to the resurgence of the S&P 500 Health Care sector in recent months, achieving a return of 29% since mid-June, outperforming the sector overall [1] Group 1: Company Performance - Merck's stock performance has been a key driver in the health care sector's recovery, indicating strong investor confidence and market positioning [1] Group 2: Market Context - The resurgence of the S&P 500 Health Care sector reflects broader market trends, with Merck playing a pivotal role in this recovery [1]

The U.S. Food and Drug Administration (FDA) is preparing to fast-track reviews of two experimental Merck & Co. Inc. (NYSE:MRK) drugs with potential blockbuster sales.Merck's cholesterol treatment enlicitide decanoate and cancer therapy sacituzumab tirumotecan (sac-TMT) have been reportedly selected for the FDA Commissioner's National Priority Voucher (CNPV) program, which accelerates regulatory decisions for medicines deemed critical to public health or national interests.If finalized, the drugs would becom ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.Top 5 Upgrades: BofA upgraded Micron (MU) to Buy from Neutral with a price target of $300, up from $250. Though there may be some volatility in AI demand, HBM is sold out again throughout calendar 2026 and customers are engaged in multi-year agreements, positioning Micron for a potentially more sustainable upcycle than in prior ...

BMO Capital将默沙东的目标价从82美元上调至130美元，评级从"与大市同步"上调至"跑赢大市"。 ...

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal! AI is eating the world—and the machines behind it are ravenous. Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink. Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and b ...